Pender NDI Life Sciences Fund invests in drug discovery and medical device companies in BC's life sciences sector.

Why Pender NDI Life Sciences?

We were the first retail venture capital fund in Canada to focus exclusively on life sciences opportunities. We believe that advances in biotechnology fields such as genomics, proteomics and bioinformatics will change our lives as much as the microelectronics industry did in the 20th century.

We have retained Dr. James Miller, one of the leading life sciences experts in Canada, to help us select attractively valued companies with drugs entering clinical trials. We invest in companies at this stage of development because their valuations can appreciate significantly as drugs move closer to regulatory approval.